￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Gefitinib (Iressa) is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor_ Kanghule

2025-10-19 11:44:20

Check Details
How much does crizotinib cost in March 2021

2025-10-19 11:44:20

Check Details
Safety, effectiveness and drug resistance of Duozerun in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The efficacy of entrectinib in the treatment of adults with metastatic ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What drug to switch to if crizotinib is not effective

2025-10-19 11:44:20

Check Details
Crizotinib price in 2021

2025-10-19 11:44:20

Check Details
Gefitinib is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that has previously received chemotherapy_ Kanghule

2025-10-19 11:44:20

Check Details
Efficacy and safety of entrectinib in patients with ROS1-positive metastatic NSCLC_ Kanghule

2025-10-19 11:44:20

Check Details
Is the targeted drug entrectinib expensive? How much does a box cost?

2025-10-19 11:44:20

Check Details
What is the effect of crizotinib?

2025-10-19 11:44:20

Check Details
What conditions need to be met before the anti-cancer drug entrectinib can be used?

2025-10-19 11:44:20

Check Details
Can gefitinib be used as first-line treatment for EGFR mutation-positive lung cancer?

2025-10-19 11:44:20

Check Details
Category
相关知识